[Hepatocellular carcinoma with cirrhosis].
Aoyagi
Y
Y
Third Division, Department of Internal Medicine, Niigata University School of Medicine, Japan.
Suzuki
Y
Y
Naitoh
A
A
D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000032:analysis; D003937:Diagnosis, Differential; D004621:Embolization, Therapeutic; D000431:Ethanol / Q000008:administration & dosage; D006498:Hepatectomy; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D008113:Liver Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D011498:Protein Precursors / Q000032:analysis; D011516:Prothrombin / Q000032:analysis; D000509:alpha-Fetoproteins / Q000032:analysis
D015415:Biomarkers; D014408:Biomarkers, Tumor; D011498:Protein Precursors; D000509:alpha-Fetoproteins; D000431:Ethanol; C008208:acarboxyprothrombin; D011516:Prothrombin